Truist Financial Reaffirms "Buy" Rating for Encompass Health (NYSE:EHC)

Encompass Health (NYSE:EHC - Get Free Report)'s stock had its "buy" rating restated by investment analysts at Truist Financial in a research note issued on Monday,Benzinga reports. They currently have a $135.00 price target on the stock, up from their previous price target of $116.00. Truist Financial's price objective points to a potential upside of 17.17% from the stock's current price.

Several other brokerages have also recently issued reports on EHC. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. William Blair reissued an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Friday. Barclays lifted their target price on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday. Finally, KeyCorp raised their price objective on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research report on Friday. Nine research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $115.86.

Encompass Health Stock Performance

Shares of EHC traded up $1.84 during trading hours on Monday, hitting $115.21. The company's stock had a trading volume of 93,254 shares, compared to its average volume of 783,738. Encompass Health has a 52-week low of $82.38 and a 52-week high of $115.00. The company has a market cap of $11.60 billion, a price-to-earnings ratio of 25.83, a PEG ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The business has a 50 day simple moving average of $100.08 and a two-hundred day simple moving average of $98.57.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. On average, equities analysts expect that Encompass Health will post 4.8 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. T. Rowe Price Investment Management Inc. purchased a new stake in Encompass Health in the fourth quarter worth $152,953,000. Norges Bank purchased a new position in Encompass Health in the 4th quarter worth about $100,637,000. Raymond James Financial Inc. bought a new stake in Encompass Health during the 4th quarter valued at about $77,944,000. Jennison Associates LLC bought a new stake in shares of Encompass Health during the fourth quarter valued at approximately $52,094,000. Finally, Farallon Capital Management LLC raised its position in Encompass Health by 15,266.7% during the 4th quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock valued at $42,573,000 after purchasing an additional 458,000 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.